The drug is a generic version of Pfizer’s combination high blood pressure and cholesterol treatment Caduet. Dr Reddy’s gained US Food and Drug Administration (FDA) approval for it abbreviated new drug application (ANDA) for generic amlodipine/atorvastatin on 7 March 2014.

Caduet (amlodipine/atorvastatin) tablets combine the calcium channel blocker amlodipine besylate with the HMG CoA-reductase inhibitor atorvastatin calcium. The drug is indicated in patients for whom treatment with both amlodipine and atorvastatin is appropriate.

Amlodipine is indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of heart attack and strokes. Amlodipine is also indicated for the treatment of coronary artery disease. Atorvastatin is indicated in addition to diet for the prevention of cardiovascular disease and high cholesterol.

Related articles

Indian generics makers face US recalls 

Dr Reddy’s and Fujifilm call off joint venture for generics in Japan

Permission granted to reproduce for personal and non-commercial use only. All other reproduction, copy or reprinting of all or part of any ‘Content’ found on this website is strictly prohibited without the prior consent of the publisher. Contact the publisher to obtain permission before redistributing.

Copyright – Unless otherwise stated all contents of this website are © 2014 Pro Pharma Communications International. All Rights Reserved.